119 related articles for article (PubMed ID: 11284066)
1. [Mortality of invasive malignant cutaneous melanoma. A review with special consideration of gender distribution].
Kölmel KF; Lippold A; Kulle B; Veltmaat S; Stoltenberg M; Seebacher C
Hautarzt; 2001 Mar; 52(3):211-8. PubMed ID: 11284066
[TBL] [Abstract][Full Text] [Related]
2. Melanoma epidemiology of Austria reveals gender-related differences.
Duschek N; Skvara H; Kittler H; Delir G; Fink A; Pinkowicz A; Waldhör T
Eur J Dermatol; 2013; 23(6):872-8. PubMed ID: 24184485
[TBL] [Abstract][Full Text] [Related]
3. Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003.
Downing A; Yu XQ; Newton-Bishop J; Forman D
Int J Cancer; 2008 Aug; 123(4):861-6. PubMed ID: 18500743
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous malignant melanoma in children and adolescents in Sweden, 1993-2002: the increasing trend is broken.
Karlsson PM; Fredrikson M
Int J Cancer; 2007 Jul; 121(2):323-8. PubMed ID: 17372908
[TBL] [Abstract][Full Text] [Related]
5. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
6. Survival probabilities and hazard functions of malignant melanoma in Germany 1972-1996, an analysis of 10433 patients. Evolution of gender differences and malignancy.
Kölmel KF; Kulle B; Lippold A; Seebacher C
Eur J Cancer; 2002 Jul; 38(10):1388-94. PubMed ID: 12091071
[TBL] [Abstract][Full Text] [Related]
7. Invasive cutaneous melanoma in The Netherlands, 1989-1990.
Tersmette AC; Coebergh JW; Casparie-van Velsen IJ; Ruiter DJ; van der Rhee HJ; Welvaart K
Eur J Cancer Prev; 1996 Feb; 5(1):69-74. PubMed ID: 8664813
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous malignant melanoma in Scotland: incidence, survival, and mortality, 1979-94. The Scottish Melanoma Group.
MacKie RM; Hole D; Hunter JA; Rankin R; Evans A; McLaren K; Fallowfield M; Hutcheon A; Morris A
BMJ; 1997 Nov; 315(7116):1117-21. PubMed ID: 9374883
[TBL] [Abstract][Full Text] [Related]
9. Melanoma in older patients: declining gap in survival between younger and older patients with melanoma.
Schuurman MS; Hollestein LM; Bastiaannet E; Posthuma EFM; van Akkooi AJC; Kukutsch NA; Aarts MJB; Wakkee M; Lemmens VEPP; Louwman MWJ
Acta Oncol; 2020 Jan; 59(1):4-12. PubMed ID: 31347929
[No Abstract] [Full Text] [Related]
10. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
[TBL] [Abstract][Full Text] [Related]
11. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
12. Survival advantage of women in localized melanoma mainly relies on clinical-pathological differences by sex. A retrospective study of 1,607 patients in Valencia, Spain.
Kindem S; Garcías-Ladaria J; Requena C; Guillén C; Oliver V; Nagore E
Eur J Dermatol; 2015; 25(3):247-54. PubMed ID: 25961331
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes in patients with multiple primary melanomas.
Rowe CJ; Law MH; Palmer JM; MacGregor S; Hayward NK; Khosrotehrani K
J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2120-7. PubMed ID: 25864459
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
15. Survival of Danish cancer patients 1943-1987. Malignant melanoma of the skin.
Osterlind A; Kjems E
APMIS Suppl; 1993; 33():149-55. PubMed ID: 8512737
[TBL] [Abstract][Full Text] [Related]
16. Malignant melanoma in Scotland 1979-1983.
MacKie RM; Smyth JF; Soutar DS; Calman KC; Watson AC; Hunter JA; McLaren KM; MacGillivray JB; McPhie JL; Rankin R
Lancet; 1985 Oct; 2(8460):859-63. PubMed ID: 2864579
[TBL] [Abstract][Full Text] [Related]
17. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
18. Sex matters: men with melanoma have a worse prognosis than women.
El Sharouni MA; Witkamp AJ; Sigurdsson V; van Diest PJ; Louwman MWJ; Kukutsch NA
J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2062-2067. PubMed ID: 31246315
[TBL] [Abstract][Full Text] [Related]
19. Improved survival for melanoma in Northern Ireland: a comparison of two 5-year periods (1984-88 and 1994-98).
McMullen EA; Kee F; Patterson CC; Gavin AT; Dolan OM
Br J Dermatol; 2004 Sep; 151(3):587-93. PubMed ID: 15377344
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous malignant melanoma in south Sweden 1965, 1975, and 1985. A histopathologic review.
Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
Cancer; 1994 Mar; 73(6):1625-30. PubMed ID: 8156490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
